Understanding Angioplasty by the Chocolate PTA Balloon Catheter Compared to Conventional PTA Balloons Via OCT Imaging
NCT ID: NCT02237066
Last Updated: 2015-03-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2014-09-30
2015-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Safety and Efficacy of Chocolate Balloon Catheter in Peripheral Arterial Disease (CHOCO-PAD)
NCT06933992
Constrained Balloon Combined With Drug-coated Balloon Angioplasty for Femoropopliteal Lesion
NCT05894460
Endovascular Treatment of Peripheral Artery Disease
NCT03346577
AcoArt Ⅱ/ BTK China: Drug-eluting Balloon for Below-The-Knee Angioplasty Evaluation in China
NCT02137577
Study of IN.PACT Amphirion™ Drug Eluting Balloon vs. Standard PTA for the Treatment of Below the Knee Critical Limb Ischemia
NCT00941733
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Chocolate PTA Balloon
Chocolate PTA Balloon Angioplasty
Chocolate PTA Balloon Angioplasty
OCT imaging of diseased vessel is treated with an Angioplasty Procedure using the Chocolate PTA Balloon Catheter followed by OCT imaging of the treated area immediately after balloon use and 10 minutes later
Standard PTA Balloon
Standard PTA Balloon Angioplasty
Standard PTA Balloon Angioplasty
OCT imaging of diseased vessel is treated with an Angioplasty Procedure using a standard PTA Balloon Catheter followed by OCT imaging of the treated area immediately after balloon use and 10 minutes later
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Chocolate PTA Balloon Angioplasty
OCT imaging of diseased vessel is treated with an Angioplasty Procedure using the Chocolate PTA Balloon Catheter followed by OCT imaging of the treated area immediately after balloon use and 10 minutes later
Standard PTA Balloon Angioplasty
OCT imaging of diseased vessel is treated with an Angioplasty Procedure using a standard PTA Balloon Catheter followed by OCT imaging of the treated area immediately after balloon use and 10 minutes later
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Intermittent claudication or critical limb ischemia (Rutherford 3-5)
* De novo stenosis (≥70%) or occlusion in the infrainguinal arteries, including superficial femoral artery (SFA), popliteal, and infrapopliteal arteries.
* Lesion successfully crossed with a guide-wire
* Patient has given informed consent to participate in this study
Exclusion Criteria
* Lesion length \>75mm
* Previous bypass or stent at target vessel or proximal to target vessel
* Significant in-flow disease at target lesion
* Known inadequate distal outflow disease or planned treatment of vessel distal to target lesion
* Acute limb ischemia or need for thrombolytic therapy
* Known intolerance to required study medications, contrast media, or nitinol
* Known impaired Renal Function with Glomerular Filtration Rate (GFR) \<45 ml/min per 1.73m2
* Known bleeding disorder or uncontrolled hypercoagulable disorder.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospitals Cleveland Medical Center
OTHER
TriReme Medical, LLC
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sahil A Parikh, MD
Role: PRINCIPAL_INVESTIGATOR
Harrington Heart and Vascular Institute University Hospitals Case Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Case Medical Center
Cleveland, Ohio, United States
Cleveland Clinic
Cleveland, Ohio, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Chocolate OCT
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.